Chen et al. also demonstrated that genomic alterations in the PTEN-phosphatidylinositol 3-kinase (PI3K) pathway, commonly mutated in glioblastoma (GBM) cells, lead to enhanced recruitment of TAMs. This evidence concerns the gene PTEN and glioblastoma.